⌘K

Home/Filings/3/0001140361-21-010618

3//SEC Filing

HASLER HANS PETER 3

Accession 0001140361-21-010618

CIK 0001819411other

View on SEC.gov Company Profile

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 7:41 PM ET

Size

3.9 KB

Accession

0001140361-21-010618

Insider Transaction Report

Form 3

Period: 2021-03-17

Gain Therapeutics, Inc.GANX

HASLER HANS PETER

Director

Holdings

Stock Option
Exercise: $3.37Exp: 2031-01-22→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]The option will be fully vested and exercisable on January 20, 2022

Documents

1 file

3
form3.xmlPrimary
FORM 3

Issuer

Gain Therapeutics, Inc.

CIK 0001819411

Entity typeother

IncorporatedMA

Related Parties

1

filerCIK 0001226286

Filing Metadata

Form type: 3
Filed: Mar 28, 8:00 PM ET
Accepted: Mar 29, 7:41 PM ET
Size: 3.9 KB

View on SEC.gov